These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 18377938)
21. Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the cardiovascular risk in young Finns study. Juonala M; Viikari JS; Kähönen M; Solakivi T; Helenius H; Jula A; Marniemi J; Taittonen L; Laitinen T; Nikkari T; Raitakari OT J Am Coll Cardiol; 2008 Jul; 52(4):293-9. PubMed ID: 18634985 [TBL] [Abstract][Full Text] [Related]
22. Birthplace differences in stroke rates among coronary heart disease patients: is variation explained by recognized risk factors? Koren-Morag N; Tanne D; Goldbourt U Isr Med Assoc J; 2009 Oct; 11(10):586-91. PubMed ID: 20077943 [TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein B as a long-term predictor of mortality in type 1 diabetes mellitus: a 15-year follow up. Stettler C; Suter Y; Allemann S; Zwahlen M; Christ ER; Diem P J Intern Med; 2006 Sep; 260(3):272-80. PubMed ID: 16918825 [TBL] [Abstract][Full Text] [Related]
24. Apolipoproteins and long-term prognosis in coronary heart disease patients. Benderly M; Boyko V; Goldbourt U Am Heart J; 2009 Jan; 157(1):103-10. PubMed ID: 19081405 [TBL] [Abstract][Full Text] [Related]
25. Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. Barter PJ; Ballantyne CM; Carmena R; Castro Cabezas M; Chapman MJ; Couture P; de Graaf J; Durrington PN; Faergeman O; Frohlich J; Furberg CD; Gagne C; Haffner SM; Humphries SE; Jungner I; Krauss RM; Kwiterovich P; Marcovina S; Packard CJ; Pearson TA; Reddy KS; Rosenson R; Sarrafzadegan N; Sniderman AD; Stalenhoef AF; Stein E; Talmud PJ; Tonkin AM; Walldius G; Williams KM J Intern Med; 2006 Mar; 259(3):247-58. PubMed ID: 16476102 [TBL] [Abstract][Full Text] [Related]
26. Bleeding increases the risk of ischemic events in patients with peripheral arterial disease. van Hattum ES; Algra A; Lawson JA; Eikelboom BC; Moll FL; Tangelder MJ Circulation; 2009 Oct; 120(16):1569-76. PubMed ID: 19805650 [TBL] [Abstract][Full Text] [Related]
27. Risk stratification of apolipoprotein B, apolipoprotein A1, and apolipoprotein B/AI ratio on the prevalence of the metabolic syndrome: the ATTICA study. Pitsavos C; Panagiotakos DB; Skoumas J; Papadimitriou L; Stefanadis C Angiology; 2008; 59(3):335-41. PubMed ID: 18388068 [TBL] [Abstract][Full Text] [Related]
28. High-density lipoprotein and the risk of recurrent venous thromboembolism. Eichinger S; Pecheniuk NM; Hron G; Deguchi H; Schemper M; Kyrle PA; Griffin JH Circulation; 2007 Mar; 115(12):1609-14. PubMed ID: 17372172 [TBL] [Abstract][Full Text] [Related]
29. [The relationship of apolipoprotein A-I and B-100 to cardiovascular diseases in aging males]. Hu XL; Bao WD; Song FR Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Feb; 16(1):11-3. PubMed ID: 7767918 [TBL] [Abstract][Full Text] [Related]
30. Apolipoproteins A-1 and B and the likelihood of non-fatal stroke and myocardial infarction -- data from The Third National Health and Nutrition Examination Survey. Qureshi AI; Giles WH; Croft JB; Guterman LR; Hopkins LN Med Sci Monit; 2002 May; 8(5):CR311-6. PubMed ID: 12011770 [TBL] [Abstract][Full Text] [Related]
31. Utility of apolipoprotein measurements in predicting incident type 2 diabetes: A Chinese cohort study. Chou YC; You SL; Bai CH; Liao YC; Wei CY; Sun CA J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):51-58. PubMed ID: 30905491 [TBL] [Abstract][Full Text] [Related]
32. Comparison of apolipoprotein B and non-high-density lipoprotein cholesterol for identifying coronary artery disease risk based on receiver operating curve analysis. Levinson SS Am J Clin Pathol; 2007 Mar; 127(3):449-55. PubMed ID: 17276939 [TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein B and insulin resistance are good markers of carotid atherosclerosis in patients with type 2 diabetes mellitus. Matsumoto K; Fujita N; Nakamura K; Senoo T; Tominaga T; Ueki Y Diabetes Res Clin Pract; 2008 Oct; 82(1):93-7. PubMed ID: 18684539 [TBL] [Abstract][Full Text] [Related]
34. The apolipoprotein story. Sacks FM Atheroscler Suppl; 2006 Aug; 7(4):23-7. PubMed ID: 16822722 [TBL] [Abstract][Full Text] [Related]
35. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma. De Bruin ML; Dorresteijn LD; van't Veer MB; Krol AD; van der Pal HJ; Kappelle AC; Boogerd W; Aleman BM; van Leeuwen FE J Natl Cancer Inst; 2009 Jul; 101(13):928-37. PubMed ID: 19535773 [TBL] [Abstract][Full Text] [Related]
36. Prediction of first events of coronary heart disease and stroke with consideration of adiposity. Wilson PW; Bozeman SR; Burton TM; Hoaglin DC; Ben-Joseph R; Pashos CL Circulation; 2008 Jul; 118(2):124-30. PubMed ID: 18591432 [TBL] [Abstract][Full Text] [Related]
38. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Langsted A; Freiberg JJ; Nordestgaard BG Circulation; 2008 Nov; 118(20):2047-56. PubMed ID: 18955664 [TBL] [Abstract][Full Text] [Related]
39. Temporal discrepancies in the association between the apoB/apoA-I ratio and mortality in incident dialysis patients. Chmielewski M; Carrero JJ; Qureshi AR; Axelsson J; Heimbürger O; Berglund L; Bárány P; Rutkowski B; Lindholm B; Stenvinkel P J Intern Med; 2009 Jun; 265(6):708-16. PubMed ID: 19298498 [TBL] [Abstract][Full Text] [Related]
40. [The determination of apolipoproteins Apo A-I and Apo B. A comparative study of methods]. Keller H; Riesen WF Z Med Lab Diagn; 1990; 31(4):200-10. PubMed ID: 2116698 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]